运动和动力步行特征与帕金森病中轻度认知障碍相关
概括
轻度认知障碍 (PD-MCI) 的帕金森病显示出明显的步态偏差. 这些步态变化可能有助于识别不同的PD表型,并改善早期检测以更好地管理患者.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 运动科学 运动科学
背景情况:
- 轻度认知障碍 (MCI) 和步态障碍在帕金森病 (PD) 中很常见.
- 早期识别PD与MCI (PD-MCI) 对于管理患者残疾和降低医疗保健成本至关重要.
- 步态分析是PD认知衰退的潜在替代标记,但PD-MCI的特定步态特征尚不清楚.
研究的目的:
- 调查PD患者与没有MCI之间的单任务和双任务行走过程中步行动力学和运动学的差异.
- 为了确定PD-MCI的潜在步态生物标志物.
- 探索步态特征是否可以区分PD表型.
主要方法:
- 在90名PD患者中收集了3D运动捕捉数据,用于步态动力学和动力学.
- 采用单变量统计分析和监督机器学习来分析步行数据.
- 在单任务和双任务行走过程中,患有或没有MCI的PD患者之间的比较步态特征.
主要成果:
- 患有MCI的PD患者 (PD-MCI) 与没有MCI的PD患者相比,表现出显著的动力学和动力学步行偏差.
- 患有PD-MCI的患者年龄较大,在临床上更受损,呈现出增加的姿势曲和更严重的轴心症状.
- 在与认知障碍相关的PD现型中观察到缺乏生理学远端到近端关节的动力转移.
结论:
- 在PD中MCI的存在与特定的步态动力学和动力学变化有关,这表明了不同的PD表型.
- 步态分析对识别PD-MCI和潜在地区分疾病亚型具有前途.
- 研究结果强调了在帕金森病中认知功能障碍,轴性症状和改变的步态生物力学之间的联系.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
04:08Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
2.8K
相关概念视频
Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
Parkinson's Disease: Overview
517
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
517
